This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1969 Sep 26;81(39):677-9.

[Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)]

[Article in German]

PMID: 5344299

[Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)]

[Article in German]

W Birkmayer. Wien Klin Wochenschr. 1969.

. 1969 Sep 26;81(39):677-9.

Author

PMID: 5344299

No abstract available

PubMed Disclaimer

Similar articles

[Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].
Kaufmann W, Butz P, Wiesendanger M. Kaufmann W, et al. Dtsch Z Nervenheilkd. 1970;197(1):85-100. Dtsch Z Nervenheilkd. 1970. PMID: 5522871 German. No abstract available.
[Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Kaufmann W, Butz P, Wiesendanger M. Kaufmann W, et al. Dtsch Z Nervenheilkd. 1969 Dec 29;197(1):85-100. Dtsch Z Nervenheilkd. 1969. PMID: 5364658 German. No abstract available.
[Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Siegfried J, Klaiber R, Perret E, Ziegler WH. Siegfried J, et al. Dtsch Med Wochenschr. 1969 Dec 26;94(52):2678-81. doi: 10.1055/s-0028-1110503. Dtsch Med Wochenschr. 1969. PMID: 4903342 Clinical Trial. German. No abstract available.
[Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
Benesová O. Benesová O. Cesk Neurol. 1973 May;36(3):196-205. Cesk Neurol. 1973. PMID: 4574253 Review. Czech. No abstract available.
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
Goodwin FK, Murphy DL, Brodie HK, Bunney WE Jr. Goodwin FK, et al. Biol Psychiatry. 1970 Oct;2(4):341-66. Biol Psychiatry. 1970. PMID: 4920729 Review. No abstract available.

See all similar articles

Cited by

[The therapeutic effect of L-dopa].
Groneberg P, Struppler A. Groneberg P, et al. Naturwissenschaften. 1972 Nov;59(11):492-6. doi: 10.1007/BF00609813. Naturwissenschaften. 1972. PMID: 4657650 German. No abstract available.
[Modern treatment of parkinsonism].
Birkmayer W, Neumayer E. Birkmayer W, et al. Z Neurol. 1972;202(4):257-80. Z Neurol. 1972. PMID: 4117647 Review. German. No abstract available.
Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase.
Marsden CD, Barry PE, Parkes JD, Zilkha KJ. Marsden CD, et al. J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):10-4. doi: 10.1136/jnnp.36.1.10. J Neurol Neurosurg Psychiatry. 1973. PMID: 4691682 Free PMC article.
Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case series.
Sethi KD, Hauser RA, Isaacson SH, McClain T. Sethi KD, et al. Cases J. 2009 Jul 30;2:7134. doi: 10.4076/1757-1626-2-7134. Cases J. 2009. PMID: 19829918 Free PMC article.
Iron, a new aid in the treatment of Parkinson patients.
Birkmayer W, Birkmayer JG. Birkmayer W, et al. J Neural Transm. 1986;67(3-4):287-92. doi: 10.1007/BF01243354. J Neural Transm. 1986. PMID: 3806082

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Research Materials
- NCI CPTC Antibody Characterization Program